Talphera: Funding, Investors & Team (Oct 2026)
Talphera is a pharmaceutical company that focuses on developing and selling therapies in medically supervised environments. They have a product called NanoTab, which is a tablet designed for oral transmucosal administration. Additionally, the company offers the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system used to manage acute postoperative pain in hospitals. They also have the Sufentanil NanoTab BTP management systems, which serve as a treatment option for patients with cancer pain. Lastly, they provide the Sufentanil/Triazolam NanoTab, which offers both analgesia and sedation for minor outpatient procedures.
Talphera has raised $8.0M across 1 funding round on record, the most recent an undisclosed round of $8.0M announced in Jan 2024.
That round is in line with the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Talphera Company Profile and Key Stats
Latest funding round on record: Jan 2024.
Talphera Funding Rounds
Talphera Founders and Leadership Team
Contact details for the Talphera team: 1 of 1 has an email address on file.
Start 14-day free trial →Talphera Funding Compared to Other Biotechnology Startups
Talphera's latest round of $8.0M is in line with the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Talphera in Biotechnology and Redwood City
Companies Similar to Talphera
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Talphera Funding FAQs
What does Talphera do?
Talphera is a pharmaceutical company that focuses on developing and selling therapies in medically supervised environments. They have a product called NanoTab, which is a tablet designed for oral transmucosal administration. Additionally, the company offers the Sufentanil NanoTab PCA system, a sublingual patient-controlled analgesia system used to manage acute postoperative pain in hospitals. They also have the Sufentanil NanoTab BTP management systems, which serve as a treatment option for patients with cancer pain. Lastly, they provide the Sufentanil/Triazolam NanoTab, which offers both analgesia and sedation for minor outpatient procedures.
How much funding has Talphera raised?
Talphera has raised $8.0M across 1 round on record. The most recent is an undisclosed round of $8.0M announced in Jan 2024.
When did Talphera last raise funding?
Talphera's most recent funding round on record is an undisclosed round of $8.0M, announced in Jan 2024.
Who founded Talphera?
FundedIQ lists Pamela Pierce Palmer (Founder) at Talphera.
Where is Talphera headquartered?
Talphera is based in Redwood City, California, United States.
How many employees does Talphera have?
Talphera is in the 11-50 employee band.
How does Talphera's funding compare to other Biotechnology startups?
Talphera's latest round of $8.0M is in line with the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Talphera Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Talphera is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.